Heritage Wealth Advisors reports 22.22% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Heritage Wealth Advisors
Latest Disclosed Ownership	1,100 shares
Latest Disclosed Value	$ 66,715

On May 13, 2026 - Heritage Wealth Advisors filed a 13F-HR form disclosing ownership of 1,100 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $57,662 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 900 shares of Bristol-Myers Squibb Company. This represents a change in shares of 22.22% during the quarter. The current value of the position is $52,173 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-13	2026-03-31	13F	Bristol-Myers Squibb	COM	110122108	1,100	200	22.22	67	37.50	0.0026
2026-02-13	2025-12-31	13F	Bristol-Myers Squibb	COM	110122108	900	0	0.00	49	20.00	0.0019
2025-11-13	2025-09-30	13F	Bristol-Myers Squibb	COM	110122108	900	0	0.00	41	-2.44	0.0018
2025-08-11	2025-06-30	13F	Bristol-Myers Squibb	COM	110122108	900	0	0.00	42	-24.07	0.0020
2025-05-08	2025-03-31	13F	Bristol-Myers Squibb	COM	110122108	900	0	0.00	55	8.00	0.0028
2025-02-12	2024-12-31	13F	Bristol-Myers Squibb	COM	110122108	900	0	0.00	51	8.70	0.0025
2024-11-12	2024-09-30	13F	Bristol-Myers Squibb	COM	110122108	900	-1,170	-56.52	47	-45.88	0.0022
2024-12-12	2024-06-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,070	-408	-16.46	86	-36.57	0.0039
2024-08-06	2024-06-30	13F	Bristol-Myers Squibb	COM	110122108	2,070	-408		86		0.0039
2024-12-12	2024-03-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,478	-1,188	-32.41	134	-28.72	0.0061
2024-05-08	2024-03-31	13F	Bristol-Myers Squibb	COM	110122108	2,478	-1,188		134		0.0062
2024-12-12	2023-12-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	3,666	1,287	54.10	188	36.23	0.0094
2024-02-12	2023-12-31	13F	Bristol-Myers Squibb	COM	110122108	2,566	187		132		0.0066
2024-12-12	2023-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,379	-203	-7.86	138	-16.36	0.0075
2023-11-09	2023-09-30	13F	Bristol-Myers Squibb	COM	110122108	2,379	-203		138		0.0075
2024-12-12	2023-06-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,582	-35	-1.34	165	-8.84	0.0087
2023-08-09	2023-06-30	13F	Bristol-Myers Squibb	COM	110122108	2,582	-35		165		0.0087
2023-05-04	2023-03-31	13F	Bristol-Myers Squibb	COM	110122108	2,617	-218	-7.69	181	-10.84	0.0101
2024-12-12	2022-12-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,835	700	32.79	204	34.44	0.0118
2023-02-07	2022-12-31	13F	Bristol-Myers Squibb	COM	110122108	2,835	700		204		0.0118
2024-12-12	2022-09-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	2,135	33	1.57	152		0.0110
2022-11-10	2022-09-30	13F	Bristol-Myers Squibb	COM	110122108	2,135	33		0		0.0110
2022-08-04	2022-06-30	13F	Bristol-Myers Squibb	COM	110122108	2,102	-64	-2.95	0		0.0113
2022-05-11	2022-03-31	13F	Bristol-Myers Squibb	COM	110122108	2,166	-1,700	-43.97	0		0.0087
2022-03-28	2021-12-31	13F/A-1	Bristol-Myers Squibb	COM	110122108	3,866	0	0.00	0	-100.00	0.0132
2022-02-02	2021-12-31	13F	Bristol-Myers Squibb	COM	110122108	3,866	0		241		0.0132
2021-11-02	2021-09-30	13F	Bristol-Myers Squibb	COM	110122108	3,866	-1,559	-28.74	229	-37.02	0.0140
2021-08-09	2021-06-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	5,425	-165	-2.95	362	2.84	0.0223
2021-07-27	2021-06-30	13F	Bristol-Myers Squibb	COM	110122108	6,164	574		382		0.0239
2021-04-27	2021-03-31	13F	Bristol-Myers Squibb	COM	110122108	5,590	-574	-9.31	353	-7.85	0.0213
2021-02-01	2020-12-31	13F	Bristol-Myers Squibb	COM	110122108	6,164	4,881	380.44	382	396.10	0.0239
2020-11-03	2020-09-30	13F	Bristol-Myers Squibb	COM	110122108	1,283	-700	-35.30	77	-33.62	0.0100
2020-07-17	2020-06-30	13F/A-1	Bristol-Myers Squibb	COM	110122108	1,983	-320	-13.89	117	-9.37	0.0163
2020-07-17	2020-06-30	13F	Bristol-Myers Squibb	COM	110122108	780	-1,523		116		16,232.9711
2020-05-05	2020-03-31	13F	Bristol-Myers Squibb	COM	110122108	2,303	475	25.98	128	9.40	0.0230
2020-02-04	2019-12-31	13F	Bristol-Myers Squibb	COM	110122108	1,828	1,063	138.95	117	207.89	0.0155
2019-10-30	2019-09-30	13F	Bristol-Myers Squibb	COM	110122108	765	-2,317	-75.18	38	-72.66	0.0056
2019-08-05	2019-06-30	13F	Bristol-Myers Squibb	COM	110122108	3,082	1,033	50.41	140	43.30	0.0214
2019-05-06	2019-03-31	13F	Bristol Myers Squibb	COM	110122108	2,049	0	0.00	98	-8.49	0.0161
2019-01-26	2018-12-31	13F	Bristol-Myers Squibb	COM	110122108	2,049	-112	-5.18	106	-20.90	0.0207
2018-11-14	2018-09-30	13F	Bristol-Myers Squibb	COM	110122108	2,161	2,161		134		0.0262
2016-10-28	2016-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	0	-3,284	-100.00	0	-100.00
2016-08-04	2016-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	3,284	3,284		241		0.1627

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.